William Blair Investment Management LLC lowered its stake in Halozyme Therapeutics, Inc. ( NASDAQ:HALO – Get Rating ) by 16.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,706,003 shares of the biopharmaceutical company's stock after selling 730,081 shares during the period. William Blair Investment Management LLC's holdings in Halozyme Therapeutics were worth $210,872,000 as of its most recent SEC filing. Other hedge funds and other institutional investors also recently modified their holdings of the company.

https://www.dailypolitical.com/2023/05/15/halozyme-therapeutics-inc-nasdaqhalo-shares-sold-by-william-blair-investment-management-llc.html

#dailypolitical